Clover Health Investments (CLOV) Gross Profit (2020 - 2026)

Clover Health Investments (CLOV) posted Gross Profit of $154.5 million for Q1 2026, up 271.21% on a QoQ basis from $41.6 million in Q4 2025, and up 41.93% year-over-year from $108.9 million in Q1 2025.

Clover Health Investments (CLOV) Gross Profit (2020 - 2026) Analysis & Trends

Clover Health Investments' Gross Profit history runs 7 years deep, the most recent figure standing at $154.5 million for Q1 2026.

  • Quarterly Gross Profit rose 41.93% year-over-year to $154.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $361.2 million (down 1.23% YoY) and the FY2025 annual result came in at $323.3 million, down 4.5% from the prior year.
  • Gross Profit was $154.5 million for Q1 2026 at Clover Health Investments, up from $41.6 million in the prior quarter.
  • Across five years, Gross Profit topped out at $1.8 billion in Q4 2022 and bottomed at -$590.3 million in Q2 2022.
  • A 5-year average of $66.0 million and a median of $70.1 million in 2023 frame the typical range for Gross Profit.
  • Peak annual rise in Gross Profit reached 18790.32% in 2022, while the deepest fall reached 4040.14% in 2022.
  • Clover Health Investments' Gross Profit stood at $1.8 billion in 2022, then slumped by 97.95% to $37.9 million in 2023, then jumped by 78.75% to $67.7 million in 2024, then slumped by 38.48% to $41.6 million in 2025, then soared by 271.21% to $154.5 million in 2026.
  • Business Quant data shows CLOV's Gross Profit at $154.5 million in Q1 2026, $41.6 million in Q4 2025, and $73.2 million in Q3 2025.

Peer Comparison

Historic Data

Download Data
DateValue